TacticScaleWhat Centene Does & How It Makes Money (CNC)
Updated October 2026 · reflects Centene's latest reported financials
Managed care company running government-sponsored and marketplace health plans. Centene gets paid to manage health coverage for its members through Medicaid, Medicare and commercial marketplace plans.
How Centene makes money
Centene gets paid to manage health coverage for its members through Medicaid, Medicare and commercial marketplace plans. It pays its network of physicians, hospitals and other providers for members' care, and it also earns revenue from its own clinics, pharmacies and specialty services.
What Centene does
Centene Corporation is a managed care company, founded in 1984 and based in Saint Louis, Missouri. It focuses on government-sponsored coverage. Its largest area of focus is Medicaid, where it runs programs such as TANF (Temporary Assistance for Needy Families), Medicaid expansion, coverage for aged, blind or disabled people, and the Children's Health Insurance Program (CHIP). It also serves foster care, long-term services and supports, and people who qualify for both Medicare and Medicaid. Beyond Medicaid, Centene offers Medicare special needs, supplement and prescription drug plans. It also sells individual and group coverage on the health insurance marketplace. A fourth segment runs clinics and pharmacies and provides vision, dental and behavioral health services, plus centralized services. Together, these businesses make Centene a major player where public healthcare programs and private insurance overlap.
Products & services
- Medicaid managed care plans
- Medicare special needs and supplement plans
- Medicare prescription drug plans
- Health insurance marketplace plans
- Vision and dental services
- Behavioral health services
What is Centene worth?
On an owner-earnings DCF, Centene's most-likely value is about $205 versus a recent price near $65 (213% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$110) with a margin of safety — so the honest verdict here is “Deeply discounted.” Fair value earns its keep only at the extremes, not in the wide middle.
On the financials alone, $65 is below even the no-growth floor ($110); the market's discount — expectations and sentiment beyond the numbers — is pricing in ≈ -6.2%/yr. A bargain only if that pessimism is overdone.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
CVS Health (CVS) · Molina Healthcare (MOH) · Humana (HUM) · The Cigna (CI) · National HealthCare (NHC)